DOI: 10.1055/s-00000005

Aktuelle Rheumatologie

References

Adler S, Reichenbach S, Gloor A. et al.
Risk of relapse after discontinuation of tocilizumab therapy in giant cell arteritis.

Rheumatology (Oxford).
2019.
DOI: 10.1093/rheumatology/kez091

Download Bibliographical Data